Literature DB >> 23375683

Incremental prognostic value of stress myocardial perfusion imaging in asymptomatic diabetic patients.

Wanda Acampa1, Mario Petretta, Stefania Daniele, Giuseppina Del Prete, Roberta Assante, Emilia Zampella, Alberto Cuocolo.   

Abstract

OBJECTIVE: Stress myocardial perfusion single-photon emission computed tomography (MPS) variables are robust estimators of prognosis. No data are available on the comparative ability of stress MPS risk markers using varied iterative and risk classification approaches in asymptomatic diabetic patients. We compared analytical approaches to estimate the added value of MPS variables in estimating coronary artery disease (CAD) outcomes in asymptomatic diabetic patients. We also evaluated the temporal characteristics of cardiac risk according to MPS findings.
METHODS: A total of 436 consecutive asymptomatic diabetic patients who underwent stress-rest gated MPS were prospectively enrolled. Multivariable Cox proportional hazards model was employed to estimate cardiac death and nonfatal myocardial infarction (MI). Risk reclassification was calculated and parametric survival analysis was used to predict time to events.
RESULTS: At multivariable analysis, post-stress left ventricular ejection fraction (LVEF) and stress MPS ischemia were independent predictors of CAD death or MI (both p < 0.01). The net reclassification improvement by adding MPS results to a model including pre-test CAD likelihood was 0.25 (95% confidence interval 0.06-0.44; p < 0.01). Parametric survival analysis showed the highest probability of CAD death or MI and the major risk acceleration in time in patients with stress MPS ischemia and post-stress LVEF ≤45%.
CONCLUSION: In asymptomatic diabetic patients, analytical approaches that establish the reclassification of events may serve for estimation of improved outcomes for stress MPS. Post-stress LVEF and stress-induced ischemia by gated MPS influence the temporal characteristic of the patient's risk at long-term follow-up.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23375683     DOI: 10.1016/j.atherosclerosis.2013.01.011

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  14 in total

1.  Screening asymptomatic patients with type 2 diabetes is recommended: Pro.

Authors:  Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2015-09-21       Impact factor: 5.952

2.  Prognostication in the era of a new stressor for myocardial perfusion imaging.

Authors:  Wanda Acampa; Marco Salvatore; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2015-02-20       Impact factor: 5.952

3.  Comparison of ESC and ACC/AHA guidelines for myocardial revascularization: are the differences clinically relevant? The European perspective.

Authors:  Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2017-04-21       Impact factor: 5.952

4.  Detection of silent myocardial ischemia: is it clinically relevant?

Authors:  Mario Petretta; Giovanni Fiumara; Maria Piera Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2013-10       Impact factor: 5.952

5.  Cardiovascular risk stratification in diabetic patients: is all in METS?

Authors:  Mario Petretta; Wanda Acampa; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2014-08-22       Impact factor: 5.952

6.  Added prognostic value of left ventricular shape by gated SPECT imaging in patients with suspected coronary artery disease and normal myocardial perfusion.

Authors:  Valeria Gaudieri; Carmela Nappi; Wanda Acampa; Emilia Zampella; Roberta Assante; Teresa Mannarino; Andrea Genova; Giovanni De Simini; Michele Klain; Guido Germano; Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2017-10-25       Impact factor: 5.952

7.  Refining risk in diabetes and CAD with SPECT MPI: New insights and future challenges.

Authors:  Syed Y Naqvi; Steven D Wittlin; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2018-02-05       Impact factor: 5.952

8.  Coronary atherosclerotic burden vs. coronary vascular function in diabetic and nondiabetic patients with normal myocardial perfusion: a propensity score analysis.

Authors:  Roberta Assante; Wanda Acampa; Emilia Zampella; Parthiban Arumugam; Carmela Nappi; Valeria Gaudieri; Mariarosaria Panico; Mario Magliulo; Christine M Tonge; Mario Petretta; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-03-14       Impact factor: 9.236

9.  Uncontrolled risk factors and worsening perfusion pattern on SPECT myocardial perfusion imaging in medically treated patients with stable chronic ischaemic heart disease.

Authors:  Claudio Marcassa; Riccardo Campini; Paolo Calza; Orazio Zoccarato
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-12       Impact factor: 9.236

10.  Warranty period of normal stress myocardial perfusion imaging in diabetic patients: a propensity score analysis.

Authors:  Wanda Acampa; Mario Petretta; Renato Cuocolo; Stefania Daniele; Valeria Cantoni; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2013-10-04       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.